Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.
- Published In:
- Frontiers in endocrinology, 16, 1716247 (2025)
- Authors:
- Kolodziej, Maciej, Opalinska, Marta, Mikolajczak, Renata, Hubalewska-Dydejczyk, Alicja, Dedecjus, Marek, Kowalska, Aldona, Saracyn, Marek, Garnuszek, Piotr, Cieszykowska, Izabela, Januszkiewicz-Caulier, Joanna, Dlugosinska, Joanna, Durma, Adam Daniel, Jozwik-Plebanek, Katarzyna, Mroz, Adrianna, Janiak, Katarzyna, Gasior-Perczak, Danuta, Trofimiuk-Muldner, Malgorzata, Sowa-Staszczak, Anna, Braziewicz, Janusz, Lenda-Tracz, Wioletta, Kacperski, Krzysztof, Budzynska, Anna, Kubik, Agata, Pastusiak, Patrycja, Chalewska, Wioletta, Borkowska, Anna, Cegla, Paulina, Walecka-Mazur, Agata, Szczodry, Artur, Kaminski, Grzegorz
- Database ID:
- RPEP-11891
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-11891APA
Kolodziej, Maciej; Opalinska, Marta; Mikolajczak, Renata; Hubalewska-Dydejczyk, Alicja; Dedecjus, Marek; Kowalska, Aldona; Saracyn, Marek; Garnuszek, Piotr; Cieszykowska, Izabela; Januszkiewicz-Caulier, Joanna; Dlugosinska, Joanna; Durma, Adam Daniel; Jozwik-Plebanek, Katarzyna; Mroz, Adrianna; Janiak, Katarzyna; Gasior-Perczak, Danuta; Trofimiuk-Muldner, Malgorzata; Sowa-Staszczak, Anna; Braziewicz, Janusz; Lenda-Tracz, Wioletta; Kacperski, Krzysztof; Budzynska, Anna; Kubik, Agata; Pastusiak, Patrycja; Chalewska, Wioletta; Borkowska, Anna; Cegla, Paulina; Walecka-Mazur, Agata; Szczodry, Artur; Kaminski, Grzegorz. (2025). Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.. Frontiers in endocrinology, 16, 1716247. https://doi.org/10.3389/fendo.2025.1716247
MLA
Kolodziej, Maciej, et al. "Dosimetry-guided peptide receptor radionuclide therapy in neuroendocrine tumors: interim safety analysis of the DUONEN trial.." Frontiers in endocrinology, 2025. https://doi.org/10.3389/fendo.2025.1716247
RethinkPeptides
RethinkPeptides Research Database. "Dosimetry-guided peptide receptor radionuclide therapy in ne..." RPEP-11891. Retrieved from https://rethinkpeptides.com/research/kolodziej-2025-dosimetryguided-peptide-receptor-radionuclide
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.